RESUMO
BACKGROUND: In the United States, reported rates of syphilis continue to increase. Co-occurring epidemics of syphilis among men who have sex with men (MSM) and heterosexual populations create challenges for the prioritization of resources and the implementation of context-specific interventions. METHODS: State was the unit of analysis and was restricted to the 44 states with the most complete data of sex or sex partners for their reported adult syphilis cases. States were classified as high, medium, or low for reported congenital syphilis (CS) and MSM primary and secondary (P&S) syphilis rates. Average values of a range of ecologic state level variables were examined among the 9 categories created through the cross-tabulation of CS and MSM P&S syphilis rates. Patterns among ecologic factors were assessed across the 9 categories of states' syphilis rates. RESULTS: Among the 44 states categorized, 4 states had high rates of both CS and MSM P&S syphilis in 2015, whereas 12 states fell into the medium/medium category and 7 into the low category. Six states had high CS and medium MSM syphilis and 4 states had medium CS but high MSM syphilis. Several area-level factors, including violent crime, poverty, insurance status, household structure and income, showed qualitative patterns with higher rates of CS and MSM P&S syphilis. Higher proportions of urban population were found among states with higher CS rates; no trend was seen with respect to urbanity and MSM P&S syphilis. CONCLUSIONS: Several area-level factors were associated with CS and MSM P&S syphilis in similar ways, whereas other ecologic factors functioned differently with respect to the 2 epidemics. Explorations of community and area-level factors may shed light on novel opportunities for population specific prevention of syphilis.
Assuntos
Minorias Sexuais e de Gênero , Sífilis/epidemiologia , Cancro/epidemiologia , Monitoramento Epidemiológico , Feminino , Heterossexualidade , Homossexualidade Masculina , Humanos , Masculino , Parceiros Sexuais , Sífilis Congênita/epidemiologia , Estados Unidos/epidemiologiaRESUMO
Sexually transmitted diseases (STDs) continue to be a global epidemic with significant risk of morbidity/mortality for the fetus. STDs with prominent cutaneous findings including condylomata acuminata, genital herpes infections, and syphilis are reviewed. Important clinical cutaneous findings help aid early diagnosis and facilitate treatment. Condylomata acuminata have the potential of causing cervical cancer, anogenital cancer, and oropharyngeal cancer. Significant advances have been made in human papilloma virus vaccinations and treatment. Genital herpes infection can produce significant physical and emotional distress to the patient and significant potential harm to the fetus. Early clinical recognition of STDs and their appropriate management is critical.
Assuntos
Antibacterianos/uso terapêutico , Antineoplásicos/uso terapêutico , Antivirais/uso terapêutico , Infecções por Papillomavirus/prevenção & controle , Vacinas contra Papillomavirus/uso terapêutico , Infecções Sexualmente Transmissíveis/terapia , Neoplasias do Colo do Útero/prevenção & controle , Aciclovir/análogos & derivados , Aciclovir/uso terapêutico , Aminoquinolinas/uso terapêutico , Cancro/diagnóstico , Cancro/tratamento farmacológico , Cancro/epidemiologia , Condiloma Acuminado/diagnóstico , Condiloma Acuminado/epidemiologia , Condiloma Acuminado/terapia , Feminino , Herpes Genital/tratamento farmacológico , Herpes Genital/epidemiologia , Humanos , Imiquimode , Infecções por Papillomavirus/epidemiologia , Penicilinas/uso terapêutico , Podofilotoxina/uso terapêutico , Infecções Sexualmente Transmissíveis/diagnóstico , Infecções Sexualmente Transmissíveis/epidemiologia , Sífilis Cutânea/diagnóstico , Sífilis Cutânea/tratamento farmacológico , Sífilis Cutânea/epidemiologia , Valaciclovir , Valina/análogos & derivados , Valina/uso terapêuticoRESUMO
BACKGROUND: This study aimed to determine the prevalence of genital ulcer and urethral pathogens, as well as their association with clinical features, in men with genital ulcer disease (GUD) enrolled in a clinical trial. METHODS: Clinical data were collected by questionnaire. Ulcer swabs were tested for herpes simplex viruses (HSV-1/2), Treponema pallidum, Haemophilus ducreyi, and Chlamydia trachomatis L1-L3. First-pass urine was tested for urethral pathogens, namely Neisseria gonorrhoeae, C. trachomatis, Trichomonas vaginalis, and Mycoplasma genitalium. Pathogens were detected by real-time molecular assays. Blood was tested for HIV, HSV-2, and syphilis-associated antibodies. Pathogens and clinical associations were investigated using the χ test. RESULTS: A total of 615 men with GUD were recruited. Herpes simplex virus (HSV-1, 4.2%; HSV-2, 98.2%) and bacterial pathogens were detected in 451 (73.6%) and 48 (7.8%) of genital ulcers, respectively. Human immunodeficiency virus, HSV-2, and treponemal antibodies were detected in 387 (62.9%), 434 (70.6%), and 141 (23.0%) men, respectively, whereas 54 men (8.8%) were rapid plasmin reagin (RPR) seropositive. A total of 223 urethral infections were diagnosed in 188 men (30.6%), including 69 (11.2%) M. genitalium, 64 (10.4%) T. vaginalis, 60 (9.8%) C. trachomatis, and 30 (4.9%) N. gonorrhoeae infections. Dysuria was reported by 170 men (27.6%), and 69 men (11.5%) had urethral discharge on examination. Urethral pathogens were detected in 102/409 (24.9%) men without these clinical features. CONCLUSIONS: Herpes accounted for most GUD cases and urethral pathogen coinfections were common. Erythromycin, dispensed to treat infrequent chancroid and lymphogranuloma venereum cases, provided additional treatment of some asymptomatic urethral pathogens. Additional antibiotics would be required to treat asymptomatic trichomoniasis and gonorrhea.
Assuntos
Cancro/epidemiologia , Infecções por Chlamydia/epidemiologia , Gonorreia/epidemiologia , Soropositividade para HIV/epidemiologia , Herpes Genital/epidemiologia , Sífilis/epidemiologia , Úlcera/epidemiologia , Úlcera/microbiologia , Doenças Uretrais/epidemiologia , Aciclovir/administração & dosagem , Adulto , Cancro/tratamento farmacológico , Infecções por Chlamydia/tratamento farmacológico , Chlamydia trachomatis/isolamento & purificação , Gonorreia/tratamento farmacológico , Soropositividade para HIV/tratamento farmacológico , HIV-1/isolamento & purificação , Haemophilus ducreyi/isolamento & purificação , Herpes Genital/tratamento farmacológico , Herpesvirus Humano 1/isolamento & purificação , Herpesvirus Humano 2/patogenicidade , Humanos , Masculino , Neisseria gonorrhoeae/isolamento & purificação , Prevalência , Atenção Primária à Saúde , Reação em Cadeia da Polimerase em Tempo Real , Vigilância de Evento Sentinela , África do Sul/epidemiologia , Inquéritos e Questionários , Sífilis/tratamento farmacológico , Treponema pallidum/isolamento & purificação , Doenças Uretrais/tratamento farmacológico , Urina/microbiologiaRESUMO
BACKGROUND: Conflicting data exist regarding whether HIV infection leads to changes in the clinical manifestations and severity of genital ulcer disease (GUD). GOAL: To determine the impact of HIV on the etiology and clinical severity of GUD. STUDY DESIGN: From July 1990 to July 1992, consecutive patients presenting to the two Baltimore City Health Department (BCHD) Sexually Transmitted Diseases clinics were approached as candidates for enrollment in a prospective study to determine factors associated with the transmission and acquisition of sexually transmitted diseases (STDs). RESULTS: Of the 1368 patients who presented to the BCHD, 214 (16%) had genital ulcerations: 160 (21%) of 757 men and 54 (9%) of 611 women. Among the patients with GUD who had undergone HIV testing, 28 (14%) of 204 were infected with HIV: 25 (17%) of 151 men and 3 (6%) of 53 women. Although both groups-those infected with HIV and those not infected with HIV--presented with GUD of similar duration (10 versus 11 days; P = 0.17), multiple lesions were found more frequently in men with HIV infection than in uninfected men: 87% versus 62% (P = 0.02). Although not statistically significant, GUD in men with HIV infection more often were deep (64% versus 44%, respectively) rather than superficial (36% versus 57%, respectively; P = 0.08), and larger (505 mm(2) versus 109 mm 2; P = 0.06). Primary syphilis caused more GUD among men with HIV infection than among uninfected men: 9 (36%) of 25 versus 24 (19%) of 126, respectively (P < 0.01). Secondary syphilis was diagnosed with concomitant GUD more frequently among men with HIV infection than among uninfected men: 3 (13%) of 25 versus 3 (2%) of 123, respectively (P < 0.01). CONCLUSIONS: In this study, patients who presented with GUD were more likely to be infected with HIV. A higher proportion of men with HIV infection had multiple lesions, and the lesions were more likely to be caused by syphilis.
Assuntos
Cancro/epidemiologia , Infecções por HIV/epidemiologia , Herpes Simples/epidemiologia , Assunção de Riscos , Adolescente , Adulto , Baltimore/epidemiologia , Cancro/complicações , Cancro/patologia , Feminino , Infecções por HIV/complicações , Herpes Simples/complicações , Herpes Simples/patologia , Humanos , Masculino , Pessoa de Meia-Idade , Estudos Prospectivos , Fatores de Risco , Inquéritos e QuestionáriosAssuntos
Cancro , Sífilis Cutânea , Antibacterianos/uso terapêutico , Cancro/diagnóstico , Cancro/epidemiologia , Cancro/terapia , Diagnóstico Diferencial , Doxiciclina/uso terapêutico , Feminino , Infecções por HIV/complicações , Soropositividade para HIV/complicações , Humanos , Incidência , Injeções Intramusculares , Masculino , Neurossífilis/diagnóstico , Penicilina G/administração & dosagem , Penicilina G Benzatina/administração & dosagem , Penicilinas/administração & dosagem , Gravidez , Complicações Infecciosas na Gravidez/tratamento farmacológico , Fatores de Risco , Sorodiagnóstico da Sífilis , Sífilis Cutânea/diagnóstico , Sífilis Cutânea/epidemiologia , Sífilis Cutânea/terapia , Sífilis Latente/diagnóstico , Tetraciclina/uso terapêuticoRESUMO
During 1986-88 and 1990-92, 1025 (97%) out of 1057 genital ulcer patients in Kigali, Rwanda, were tested for HIV antibodies and for infection with Treponema pallidum, Haemophilus ducreyi and herpes simplex virus. Overall, 57% of men and 80% of women had antibodies to HIV-1. The most frequent laboratory diagnoses were chancroid (27%), syphilis (19%) and genital herpes (19%) among men and syphilis (35%), genital herpes (23%) and chancroid (20%) among women. HIV-1 seroprevalence increased sharply over time among men but not among women. The clinical presentation of ulcers as well as laboratory diagnoses were similar in the HIV-1 seropositive and seronegative groups. The relative frequency of all laboratory diagnoses remained unchanged over time. HIV-1 seropositivity had no impact on ulcer healing. Advanced immunodeficiency was diagnosed among 12% of the HIV-1 seropositive patients and was significantly associated with increasing age and genital herpes.
PIP: A study conducted at the Centre Medico-Social de Bilyogo, a primary health clinic located in an area of Nyamirambo, Kigali (Rwanda), where prostitution is widespread, assessed the frequencies of the causes of genital ulcer disease. Out of 1057 consecutive genital ulcer patients tested in 1986-88, 57% of men and 80% of women were infected with HIV-1. The most frequent laboratory diagnoses were chancroid (27%), syphilis (19%), and genital herpes (19%) among men and syphilis (35%), genital herpes (23%), and chancroid (20%) among women. During follow-up in 1990-92, HIV-1 seroprevalence increased sharply among men of all ages and women under 30 years of age. HIV-1 seropositivity had no effect on the clinical presentation of ulcers or on the time required for ulcer healing. Advanced immunodeficiency, diagnosed among 12% of HIV-positive patients, was significantly associated with increasing age and genital herpes.
Assuntos
Infecções Oportunistas Relacionadas com a AIDS/epidemiologia , Cancro/epidemiologia , Cancroide/epidemiologia , Soroprevalência de HIV , HIV-1 , Herpes Genital/epidemiologia , Adulto , Assistência Ambulatorial , Cancro/diagnóstico , Cancroide/diagnóstico , Distribuição de Qui-Quadrado , Feminino , Herpes Genital/diagnóstico , Humanos , Masculino , Valor Preditivo dos Testes , Atenção Primária à Saúde , Ruanda/epidemiologia , Sensibilidade e Especificidade , Estatísticas não ParamétricasAssuntos
Humanos , Masculino , Feminino , Adolescente , Adulto , Pessoa de Meia-Idade , Infecções Sexualmente Transmissíveis/patologia , Infecções Sexualmente Transmissíveis/prevenção & controle , Infecções Sexualmente Transmissíveis/terapia , Infecções Sexualmente Transmissíveis/transmissão , Infecções Sexualmente Transmissíveis/epidemiologia , Cancro/epidemiologia , Educação em Saúde/métodos , Educação em Saúde/normas , Educação em Saúde , Educação Sexual/métodos , Educação Sexual/normas , Educação Sexual , Sífilis/epidemiologia , Herpes Genital/epidemiologia , Estatísticas de SaúdeAssuntos
Infecções Sexualmente Transmissíveis/epidemiologia , Adolescente , Adulto , Cancro/epidemiologia , Infecções por Chlamydia/epidemiologia , Infecções por Chlamydia/microbiologia , Chlamydia trachomatis , Europa (Continente)/epidemiologia , Feminino , Gonorreia/epidemiologia , Herpes Genital/epidemiologia , Humanos , Masculino , Papillomaviridae , Sífilis/epidemiologia , Infecções Tumorais por Vírus/epidemiologiaRESUMO
En el periodo comprendido de enero a diciembre de 1990 tuvimos la ocasion de observar por primera vez en nuestro hospital un brote epidemico de chancro blando en 55 pacientes incluidos entre otros 142 pacientes con diferentes sexualmente transmitibles. En 22 de ellos el diagnostico clinico fue confirmado por examen directo y cultivo de agar chocolate, 20 correspondian al sexo masculino y 2 al femenino. Las caracteristicas de todos los pacientes eran similares a los reportados en la literatura. En algunos casos observamos asociacion con otras enfermedades de transmision sexual. Este es el primer reporte de chancro blando observado en nuestro pais y aparecido con caracter epidemico coincidente con un aumento en la frecuencia de la enfermedad a nivel mundial. El tratamiento con eritromicina o co-trimoxozol resulto exitoso para la totalidad de los casos utilizados